Aurora Cannabis Q3 2024 Earnings Presentation February

Aurora Cannabis reports record adjusted EBITDA of $4.3M in Q3 2024, marking five consecutive quarters of positive adjusted EBITDA. The company has delivered $400M in cost efficiencies over three years and maintains a $200M cash position, enabling pursuit of profitable growth across its global medical cannabis operations in 15 countries.